SU1629062A1 - Method for treatment of calves with colibacillosis - Google Patents
Method for treatment of calves with colibacillosis Download PDFInfo
- Publication number
- SU1629062A1 SU1629062A1 SU853866460A SU3866460A SU1629062A1 SU 1629062 A1 SU1629062 A1 SU 1629062A1 SU 853866460 A SU853866460 A SU 853866460A SU 3866460 A SU3866460 A SU 3866460A SU 1629062 A1 SU1629062 A1 SU 1629062A1
- Authority
- SU
- USSR - Soviet Union
- Prior art keywords
- treatment
- colibacillosis
- dose
- calves
- neovietin
- Prior art date
Links
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Description
1one
(21)3866460/15 (22)07.03.85 (46)23.02.91. Бюл. № 7(21) 3866460/15 (22) 07.03.85 (46) 23.02.91. Bul № 7
(71)Казахский научно-исследовательский ветеринарный институт Восточного отделени ВАСХНИЛ(71) Kazakh Research Veterinary Institute of the Eastern Branch of the Academy of Agricultural Sciences
(72)Л.А.Афанасьев, В.А.Гушул, В.М.Петров, А.З.Мзуланов и Т.П.Мантрова (53)616.981.48(088.8)(72) L.A.Afanasyev, V.A.Gushul, V.M.Petrov, A.Z.Mzulanov and T.P.Mantrova (53) 616.981.48 (088.8)
(56) Временное наставление по применению этони при бактериальных желудочно- кишечных заболевани х тел т и порос т. Утв. ГУ В Минсельхоза СССР 31 08,78.(56) Temporary guidance on the use of etoni in bacterial gastrointestinal diseases of bodies and pigs. App. State In the Ministry of agriculture of the USSR 31 08.78.
Рекомендации по профилактике и лечению колибактериоза тел т. - Изд-во: Кай- нар, 1975.Recommendations for the prevention and treatment of colibacteriosis tel. - Publisher: Caynar, 1975.
Авторское свидетельство СССР № 989770, кл. А 61 К 31/00, 1977.USSR Author's Certificate No. 989770, cl. A 61 K 31/00, 1977.
(54) СПОСОБ ЛЕЧЕНИЯ КОЛИБАКТЕРИОЗА ТЕЛЯТ(54) METHOD OF TREATMENT OF COLIBACTERIOSIS OF CALVES
(57) Изобретение относитс к ветеринарии, и может быть использовано дл лечени колибактериоза тел т. Цель изобретени - по- вышение эффективности способа при осложнении заболевани другой патогенной микрофлорой. Тел там, больным коли- бактериозом, осложненным другими патогенными культурами, ввод т перораль- но антибиотик неоветин в дозе 10-12 мг/кг и алкилдиметиламмоний хлорид (катамин АБ) в дозе 10-30 мг/кг 2-3 раза в сутки. При сочетанном их введении наблюдаетс сине- ргидна эффективность, повышаетс терапевтическа эффективность, сокращаетс курс лечени . 3 табл.(57) The invention relates to veterinary medicine, and can be used for the treatment of colibacillosis of the body. The purpose of the invention is to improve the efficiency of the method in complicating a disease with another pathogenic microflora. Bodies there, patients with colibacillosis complicated by other pathogenic cultures, administered orally neo-vetin antibiotic at a dose of 10-12 mg / kg and alkyl dimethyl ammonium chloride (katamin AB) at a dose of 10-30 mg / kg 2-3 times a day. When combined, their administration shows synephrogenic efficacy, increases therapeutic efficacy, reduces the course of treatment. 3 tab.
уat
ЁYo
Изобретение относитс к ветеринарии и может быть использовано дл лечени колибактериоза тел т.The invention relates to veterinary medicine and can be used for the treatment of colibacteriosis tel.
Цель изобретени - повышение эффективности способа при осложнении заболевани другой патогенной микрофлорой.The purpose of the invention is to increase the efficiency of the method in case of complication of the disease with another pathogenic microflora.
Пример. Тел т, больных колибакте- риозом, осложненным другими патогенными культурами, разделили на три группы. Первой группе тел т вводили водный раствор неоветина в дозе 10-12 мг/кг, второй группе тел вводили неоветин в дозе 10-12 мг/кг в сочетании с 0,1 %-ным водным раствором алкилдиметиламмоний хлорида (катамин АБ) в дозе 10-30 мг/кг и треть группа тел т получала неоветин в той же дозе в сочетании с водным раствором этони . Введение осуществл ли пероральноExample. The bodies of patients with colibacteriosis complicated by other pathogenic cultures were divided into three groups. The first group of calves was injected with an aqueous solution of neovietin at a dose of 10-12 mg / kg, the second group of bodies was administered neo-vetin at a dose of 10-12 mg / kg in combination with a 0.1% aqueous solution of alkyl dimethyl ammonium chloride (katamin AB) at a dose of 10 -30 mg / kg and a third group of tel received neovietin in the same dose in combination with an aqueous solution of etoni. The introduction was carried out orally
Данные о эффективности лечени в зависимости от сочетани антибиотика неоветина и поверхностно-активного вещества представлены в табл. 1.Data on the effectiveness of treatment, depending on the combination of neovietin antibiotic and surfactant, are presented in table. one.
В табл. 2 приведены результаты эффективности лечени в зависимости от дозы катамина АБ.In tab. 2 shows the results of treatment efficacy depending on the dose of catamine AB.
Однократное применение неоветина с катамином АБ малоэффективно, а 2-3-кратное введение препарата вы вл ет наибольшую терапевтическую эффективность и сокращает до минимума курс лечени .A single use of neovietin with catamine AB is ineffective, and 2-3 times the administration of the drug reveals the greatest therapeutic efficacy and reduces the course of treatment to a minimum.
В табл. 3 приведены данные по воздействию катамина АБ на устойчивость микроорганизмов при минимально-подавл ющей концентрации (МПК).In tab. Table 3 shows the data on the effect of catamine AB on the resistance of microorganisms with a minimum suppressive concentration (MIC).
ОABOUT
ю ю о оyu o about o
юYu
При сочетании воздействи антибиотика и катамина АБ на микробную клетку наблюдаетс синергидна эффективность.When a combination of antibiotic and catamine AB is applied to the microbial cell, synergistic efficacy is observed.
Claims (1)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
SU853866460A SU1629062A1 (en) | 1985-03-07 | 1985-03-07 | Method for treatment of calves with colibacillosis |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
SU853866460A SU1629062A1 (en) | 1985-03-07 | 1985-03-07 | Method for treatment of calves with colibacillosis |
Publications (1)
Publication Number | Publication Date |
---|---|
SU1629062A1 true SU1629062A1 (en) | 1991-02-23 |
Family
ID=21166730
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SU853866460A SU1629062A1 (en) | 1985-03-07 | 1985-03-07 | Method for treatment of calves with colibacillosis |
Country Status (1)
Country | Link |
---|---|
SU (1) | SU1629062A1 (en) |
-
1985
- 1985-03-07 SU SU853866460A patent/SU1629062A1/en active
Similar Documents
Publication | Publication Date | Title |
---|---|---|
RU95101385A (en) | Products containing g-csf and tnf-binding protein | |
US4749568A (en) | Rubradirin treatment of methicillin-resistant staph | |
Farber | Clinical and biological studies with actinomycins | |
SU1629062A1 (en) | Method for treatment of calves with colibacillosis | |
Rosenberg et al. | Antibiotic TA: an adherent antibiotic | |
AU5643299A (en) | Humic acid and its use in the treatment of various conditions | |
CA2383626A1 (en) | Treatment of dermal tumors, warts, and viral infections using heat-killed p. acnes | |
CA1285226C (en) | Compositions containing a 2,4-diamino-pyrimidine and sulphadimidine | |
RU2188001C2 (en) | Method for treating myxomatosis and viral hemorrhagic diseases in rabbits | |
US4092411A (en) | Antibacterial composition | |
RU2180221C2 (en) | Method to treat subclinical mastitis in cows | |
RU2030180C1 (en) | Method for treatment of endometritis at cow | |
RU2258501C2 (en) | Method for applying ethidium bromide for treatment of horses with pyroplasmosis | |
RU2221579C2 (en) | Method for treating mastitis in cows | |
RU2678082C1 (en) | Method for treating pigs in case of dysentery and other bacterial diseases | |
RU1826911C (en) | Method of prophylaxis and treating atherosclerosis in experiment | |
RU2134956C1 (en) | Method of calf breeding | |
Shinashal | The capability of camels urine in the treatment of infection caused by Escherichia coli and Staphylococcus aureus | |
RU2224508C2 (en) | Preparation for treating purulent-necrotic lesions of limbs in cattle and method for its application | |
RU2179846C2 (en) | Preparation to treat and prevent gastrointestinal and respiratory diseases in calves | |
RU2220717C2 (en) | Preparation for treatment of canine parvoviral enteritis and method for its application | |
RU2229889C2 (en) | Immunomodulator for furred animals | |
RU2058143C1 (en) | Method of treatment of acute respiratory disease in agriculture animal young stock | |
RU2228742C2 (en) | Method for treating relapsing equine iridocyclochorioiditis | |
RU2223755C1 (en) | Method for treating equine relapsing iridocyclochorioiditis |